Associazione Medici Endocrinologi€¦ · 417 patients with metastatic, RAI-resistant DTC,...
Home
/
Documents
Post on 28-Jun-2020
2 views
0 download
Preview:
Click to see full reader
Report this document
SHARE
transcript
Page 1
Page 2
Page 3
Page 4
Page 5
Page 6
Page 7
Page 8
Page 9
Page 10
Page 11
Page 12
Page 13
Page 14
Page 15
Page 16
Page 17
Page 18
Page 19
Page 20
Page 21
Page 22
Page 23
Page 24
Page 25
Page 26
Page 27
Page 28
Page 29
Page 30
Page 31
Page 32
Page 33
Page 34
Page 35
Page 36
Page 37
Page 38
Page 39
Page 40
Page 41
Page 42
Page 43
Page 44
Page 45
Page 46
Page 47
Page 48
Page 49
Page 50
Page 51
Page 52
Page 53
Page 54
Page 55
Page 56
Page 57
Page 58
Top related
Sorafenib Side effects and dose adjustment · Sorafenib-Side effects and dose adjustment - Adverse events: prevention and management as key • Patients should be informed to: –
Documents
Sorafenib-Induced Hepatocellular Carcinoma Cell Death ...Molecular Medicine in Practice Sorafenib-Induced Hepatocellular Carcinoma Cell Death DependsonReactiveOxygenSpeciesProductionInVitroand
Documents
Clinical Policy: Sorafenib (Nexavar)€¦ · Clinical Policy: Sorafenib (Nexavar) Reference Number: CP.PHAR.69 Effective Date: 07.01.11 Last Review Date: 05.19 Line of Business: Commercial,
Documents
In Hepatocellular Carcinoma miR-221 Modulates Sorafenib … · Biology of Human Tumors In Hepatocellular Carcinoma miR-221 Modulates Sorafenib Resistance through Inhibition of Caspase-3–Mediated
Documents
Intermediate stage HCC treatment options: TACE + sorafenib.
Documents
Clinical Policy: Sorafenib (Nexavar) · 2020-04-30 · Clinical Policy: Sorafenib (Nexavar) Reference Number: CP.PHAR.69 Effective Date: 07.01.11 Last Review Date: 05.19 Line of Business:
Documents
Abbreviated Title: Phase II trial of Sorafenib+Bevacizumab ...
Documents
PPARδ Reprograms Glutamine Metabolism in Sorafenib ... · Metabolism PPARd Reprograms Glutamine Metabolism in Sorafenib-Resistant HCC Mi-Jin Kim1,2,Yeon-Kyung Choi1,3, Soo Young
Documents
Targeted Delivery of Anti-Cancer Drug Sorafenib through ...Sorafenib is an anticancer drug approved by the Food and Drug Administration for the treatment of hepatocellular carcinoma
Documents
TDM du Sorafenib - OncoRésonanceoncoresonance.fr/gpco/wp-content/uploads/2016/12/Benoit-Blanchet-GPCO16-2.pdf · regression analysis indicated that sorafenib exposure was related
Documents
Pericytes Elicit Resistance to Vemurafenib and Sorafenib ... · Pericytes Elicit Resistance to Vemurafenib and Sorafenib Therapy in Thyroid Carcinoma via the TSP-1/TGFb1 Axis Alessandro
Documents
5‑fluorouracil enhances the antitumor effect of sorafenib ...
Documents
Sorafenib-induced defective autophagy promotes cell death by ...
Documents
Sorafenib, a multikinase inhibitor, induces formation of ...€¦ · Sorafenib (Nexavar®), an Raf1/Mek/Erk kinase inhibitor approved for advanced hepatocarcinoma cells (HCC) [35],
Documents
Evaluation of sorafenib for advanced hepatocellular carcinoma … · Sorafenib (Nexavar; Bayer Healthcare, Leverkusen, Ger-many) is an oral multi-targeted tyrosine kinase inhibitor
Documents
Sorafenib and HCC: Is It All About VEGF?
Documents
Clinical Policy: Sorafenib (Nexavar) - Superior HealthPlan · 2020-06-10 · Sorafenib (Nexavar ®) is a kinase inhibitor. FDA Approved Indication(s) Nexavar (sorafenib) is indicated
Documents
Sorafenib Improves Efficacy in the Treatment of Cirrhotic …...Combination Therapy with a Liver Selective Acetyl CoA Carboxylase Inhibitor ND-654 and Sorafenib Improves Efficacy in
Documents
Sequence‑dependent effect of sorafenib in combination with ...
Documents
Acetylsalicylic Acid Governs the Effect of Sorafenib in RAS-Mutant … · Cancer Therapy: Preclinical Acetylsalicylic Acid Governs the Effect of Sorafenib in RAS-Mutant Cancers Heinz
Documents